1 , 31 Nevertheless, in accord with our study, it seemed that differences between levetiracetam and other AEDs in respect of seizure-free rate, seizure-frequency reduction from baseline, and occurrence rate of adverse events did not reach statistical significance.
← all excerpts
A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy.
1
—
—